Keyword: MERS

HPV

Regeneron, BARDA partner to develop MERS virus treatment

Regeneron Pharmaceuticals and the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) have done a deal to develop a pair of antibodies to prevent and treat Middle East Respiratory Syndrome (MERS).